These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome. Lee JW J Clin Psychopharmacol; 2010 Feb; 30(1):3-10. PubMed ID: 20075641 [TBL] [Abstract][Full Text] [Related]
23. [Medical emergencies caused by neuroleptic therapy]. Charbonneau M; Denis JF Union Med Can; 1986 Sep; 115(9):648-51, 666. PubMed ID: 2877516 [No Abstract] [Full Text] [Related]
24. Catatonia, neuroleptics and brain damage--a case report. Chandran M; El-Shazly M J Psychopharmacol; 2009 Mar; 23(2):223-6. PubMed ID: 18562406 [TBL] [Abstract][Full Text] [Related]
25. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine. Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089 [TBL] [Abstract][Full Text] [Related]
26. [Malignant neuroleptic syndrome: An atypical case in an adolescent affected by bipolar I disorder associated with catatonic syndrome]. Fernandez A; Pendaries G; Dor E; Askenazy F; Thümmler S Encephale; 2020 Apr; 46(2):153-154. PubMed ID: 31522832 [No Abstract] [Full Text] [Related]
27. Catatonia in psychiatric classification. Van Den Eede F; Sabbe B Am J Psychiatry; 2004 Dec; 161(12):2327-8; author reply 2328. PubMed ID: 15569914 [No Abstract] [Full Text] [Related]
28. Dantrolene in lethal catatonia. Pennati A; Sacchetti E; Calzeroni A Am J Psychiatry; 1991 Feb; 148(2):268. PubMed ID: 1670981 [No Abstract] [Full Text] [Related]
29. The genetics of drug-related movement disorders (DRMD), reply to comment: Antipsychotic-induced catatonia and neuroleptic malignant syndrome: The dark side of the moon. van der Burg NC; Al Hadithy AFY; van Harten PN; van Os J; Bakker PR Mol Psychiatry; 2021 Nov; 26(11):6115. PubMed ID: 34244618 [No Abstract] [Full Text] [Related]
30. Movement disorders and the treatment of schizophrenia. Ellard J Australas Psychiatry; 2004 Dec; 12(4):409. PubMed ID: 15715820 [No Abstract] [Full Text] [Related]
31. [Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports]. Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Casamassima F; Litta A; Mauri M; Cassano GB Riv Psichiatr; 2012; 47(2):178-85. PubMed ID: 22622253 [TBL] [Abstract][Full Text] [Related]
32. Catatonia: harbinger of the neuroleptic malignant syndrome. White DA; Robins AH Br J Psychiatry; 1991 Mar; 158():419-21. PubMed ID: 1674666 [TBL] [Abstract][Full Text] [Related]
33. Clinical risk factors for neuroleptic malignant syndrome. Berardi D; Dell'Atti M; Amore M; De Ronchi D; Ferrari G Hum Psychopharmacol; 2002 Mar; 17(2):99-102. PubMed ID: 12404699 [TBL] [Abstract][Full Text] [Related]